Literature DB >> 28296827

Vedolizumab Is Safe and Effective in Elderly Patients with Inflammatory Bowel Disease.

Udayakumar Navaneethan1, Timothy Edminister, Xiang Zhu, Kiran Kommaraju, Sarah Glover.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28296827     DOI： 10.1097/MIB.0000000000001071

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  13 in total

Review 1.  Management of Ulcerative Colitis in the Elderly.

Authors:  Manish P Shrestha; Sasha Taleban
Journal:  Drugs Aging       Date:  2019-01       Impact factor: 3.923

Review 2.  Vaccination in the Elderly and IBD.

Authors:  Anthony J Choi; Preston Atteberry; Dana J Lukin
Journal:  Curr Treat Options Gastroenterol       Date:  2019-12

3.  Efficacy and safety of vedolizumab in elderly patients with inflammatory bowel disease: a matched case-control study.

Authors:  Preeti Shashi; Dharmesh Gopalakrishnan; Malav P Parikh; Bo Shen; Gursimran Kochhar
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-09-17

Review 4.  A Comprehensive Review of the Diagnosis and Pharmacological Management of Crohn's Disease in the Elderly Population.

Authors:  David Kim; Sasha Taleban
Journal:  Drugs Aging       Date:  2019-07       Impact factor: 3.923

5.  Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study.

Authors:  Nathaniel Aviv Cohen; Nikolas Plevris; Uri Kopylov; Anna Grinman; Bella Ungar; Henit Yanai; Haim Leibovitzh; Naomi Fliss Isakov; Ayal Hirsch; Einat Ritter; Yulia Ron; Ariella Bar-Gil Shitrit; Eran Goldin; Iris Dotan; Shomron Ben Horin; Charlie W Lees; Nitsan Maharshak
Journal:  United European Gastroenterol J       Date:  2020-08-17       Impact factor: 4.623

Review 6.  Vedolizumab in Inflammatory Bowel Disease: West versus East.

Authors:  Prasanta Debnath; Pravin M Rathi
Journal:  Inflamm Intest Dis       Date:  2021-01-27

Review 7.  Management of inflammatory bowel disease in older persons: evolving paradigms.

Authors:  Saurabh Kedia; Jimmy K Limdi; Vineet Ahuja
Journal:  Intest Res       Date:  2018-04-30

Review 8.  A review of vedolizumab and ustekinumab for the treatment of inflammatory bowel diseases.

Authors:  Hang Hock Shim; Pak Wo Chan; Sai Wei Chuah; Brian J Schwender; San Choon Kong; Khoon Lin Ling
Journal:  JGH Open       Date:  2018-06-20

9.  Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease.

Authors:  Stefan Schreiber; Axel Dignass; Laurent Peyrin-Biroulet; Greg Hather; Dirk Demuth; Mahmoud Mosli; Rebecca Curtis; Javaria Mona Khalid; Edward Vincent Loftus
Journal:  J Gastroenterol       Date:  2018-06-04       Impact factor: 7.527

10.  Factors influencing the outcome of vedolizumab treatment: Real-life data with objective outcome measurements.

Authors:  Orla Mader; Pascal Juillerat; Luc Biedermann; Pierre Michetti; Petr Hruz; Valerie Pittet; Gerhard Rogler; Nadine Zahnd-Straumann; Frank Seibold
Journal:  United European Gastroenterol J       Date:  2021-02-26       Impact factor: 4.623
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.